Rx-To-OTC Switch Risks, Benefits Quantification Needed - FDA's Woodcock
This article was originally published in The Tan Sheet
Executive Summary
Risks of self-medical management must be quantified so they can be weighed against benefits generated by an Rx-to-OTC switch, Center for Drug Evaluation & Research Director Janet Woodcock, MD, said Oct. 29.